May. 28 at 3:02 PM
$MDWD management leaves questions, but the product itself is solid.
At ~14.5, there is already an FDA-approved product on market, with manufacturing sites pending approval that was recently delayed, and the Phase 3 FDA catalyst now pushed to Q1 2027.
No near-term catalysts, more of a wait-and-see setup, suitable only for a small position.
Do your own research and understand the situation before following.
